Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Clarke, WT; Papamichael, K; Vande Casteele, N; Germansky, KA; Feuerstein, JD; Melmed, GY; Siegel, CA; Irving, PM; Cheifetz, AS

Published Date

  • October 18, 2019

Published In

Volume / Issue

  • 25 / 11

Start / End Page

  • e143 - e145

PubMed ID

  • 31559417

Pubmed Central ID

  • 31559417

Electronic International Standard Serial Number (EISSN)

  • 1536-4844

Digital Object Identifier (DOI)

  • 10.1093/ibd/izz202

Language

  • eng

Conference Location

  • England